title: Fatal intracerebral hemorrhage associated with administration of recombinant tissue plasminogen activator in a stroke patient on treatment with dabigatran.
authors: Department of Neurology, Stroke Unit, Hospital San Pedro de Alcántara, Cáceres, Spain. icasadon@gmail.com
authors: Ignacio
authors: I
authors: Casado Naranjo
authors: Juan Carlos
authors: JC
authors: Portilla-Cuenca
authors: Pedro Enrique
authors: PE
authors: Jiménez Caballero
authors: Maria Luisa
authors: ML
authors: Calle Escobar
authors: Raúl Mauricio
authors: RM
authors: Romero Sevilla
mesh_terms: D001281:Atrial Fibrillation / Q000150:complications / Q000628:therapy; D001562:Benzimidazoles / Q000009:adverse effects* / Q000627:therapeutic use; D002543:Cerebral Hemorrhage / Q000139:chemically induced* / Q000150:complications; D002560:Cerebrovascular Circulation; D000069604:Dabigatran; D004554:Electric Countershock; D017809:Fatal Outcome; D005343:Fibrinolytic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D020521:Stroke / Q000139:chemically induced* / Q000209:etiology; D010959:Tissue Plasminogen Activator / Q000009:adverse effects* / Q000627:therapeutic use; D014057:Tomography, X-Ray Computed; D015091:beta-Alanine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D001562:Benzimidazoles; D005343:Fibrinolytic Agents; D015091:beta-Alanine; D010959:Tissue Plasminogen Activator; D000069604:Dabigatran